Let's talk medical research

At Antidote, our mission is to connect patients with clinical trials is only possible when we understand the individuals that make up the patient population. One way we are able to gain this understanding is by providing our clinical trial search tool, Antidote Match, at no cost to over 300 organizations that we partner with.

Before any new therapy can be put on the market, it must be tested to ensure its safety and effectiveness, and the research for this process is done through clinical trials. Clinical trials evaluate new drugs, devices, packaging, and behaviors in order to determine if these potential therapies work for particular conditions or patient populations.

At Antidote, our primary mission is to make a connection between patients and clinical trial enrollment opportunities. Our key tool for achieving this goal is Antidote Match, a unique and proprietary clinical trial search platform. By answering a few questions, users are able to quickly see which trials they may be eligible for — and this is made possible through the Antidote annotation process. ...

IgA nephropathy, also known as IgAN or Berger disease, is a common kidney disease that can impact any individual at any age. It is one of the most prevalent kidney diseases other than those caused by diabetes or high blood pressure, but the cause and the cure for this condition remain unknown.

Completing any multi-part task requires organization, coordination, and discipline — and, of course, clinical trials are no exeption. Planning a research study, launching a trial, and keeping things running smoothly requires knowledge and expertise, which is why clinical trial project managers are so vital to the process.

In the medical research industry, successful clinical trial patient recruitment is a known roadblock — in fact, 85% of studies fail to recruit enough patients to complete the research. There are many factors that amplify clinical trial recruitment challenges, but there are also strategic solutions that can be employed for better success.

For medical research to advance, the participation of individuals in a clinical trial is essential. However, accessing trial sites can present an undue burden. A survey about barriers to clinical trial participation found that the primary reason patients declined to enroll in a study was due to the inconvenience associated with travel. This is backed up by research from Deloitte, which reveals ...

Clinical trial recruitment is a significant challenge for sponsors as insufficient patient enrollment can account for delays in up to 80% of all studies. However, even when these studies successfully reach their randomization targets, clinical trial managers must turn their focus on retaining these participants.

Participating in a clinical trial is a significant decision for patients, and several factors can influence their decision to enroll. These factors include understanding the trial's details, goals, and logistics. Sponsors must understand what matters most to patients when designing protocols, and prioritizing patient-centric considerations is key to enhancing patient engagement and trial success.

While randomizing patients into a clinical trial is a key part of advancing medical breakthroughs, reaching adequate patient enrollment numbers still poses a challenge for sponsors, sites, and research staff. It is not uncommon for trials to close due to a lack of enrollment, which results in significant costs, wasted resources, and stifled research advancement.